AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and i...
Puma AIM VCT Increases Share Capital With Admission of New Ordinary Shares
Aimia Steps Up Share Buybacks to Narrow Discount to Intrinsic Value
Aimia Q4 Earnings Call Highlights
Aimia boosts cash, trims costs and moves to sell Bozzetto as 2025 earnings stabilize
Aimia Declares Quarterly Dividends on Preferred Shares
Stocks in Play: Aimia Inc.